方案：在让利益相关者参与健康和医疗保健指南制定过程中的利益冲突问题：一项系统综述。
PROTOCOL: Conflict of interest issues when engaging stakeholders in health and healthcare guideline development: a systematic review.
作者信息
Khabsa Joanne, Petkovic Jennifer, Riddle Alison, Lytvyn Lyubov, Magwood Olivia, Atwere Pearl, Campbell Pauline, Katikireddi Srinivasa V, Merner Bronwen, Nasser Mona, Chang Stephanie, Jaramillo Garcia Alejandra, Limburg Heather, Guise Jeanne-Marie, Tugwell Peter, Akl Elie A
机构信息
Clinical Research Institute American University of Beirut Medical Center Beirut Lebanon.
Bruyère Research Institute University of Ottawa Ottawa Canada.
出版信息
Campbell Syst Rev. 2022 Apr 16;18(2):e1232. doi: 10.1002/cl2.1232. eCollection 2022 Jun.
Abstract
This is the protocol for a Campbell systematic review. The overall objective of this study is to gather and summarize the existing literature on conflict of interest issues when engaging stakeholders in guideline development.
摘要
这是一项坎贝尔系统评价的方案。本研究的总体目标是收集和总结在让利益相关者参与指南制定时关于利益冲突问题的现有文献。
相似文献
1
PROTOCOL: Conflict of interest issues when engaging stakeholders in health and healthcare guideline development: a systematic review.方案：在让利益相关者参与健康和医疗保健指南制定过程中的利益冲突问题：一项系统综述。
Campbell Syst Rev. 2022 Apr 16;18(2):e1232. doi: 10.1002/cl2.1232. eCollection 2022 Jun.
2
Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation.卫生与医疗保健指南制定和实施中利益相关者参与指南制定的指导方针制定议定书。
Syst Rev. 2020 Feb 1;9(1):21. doi: 10.1186/s13643-020-1272-5.
3
PROTOCOL: Barriers and facilitators to stakeholder engagement in health guideline development: A qualitative evidence synthesis.方案：利益相关者参与健康指南制定的障碍与促进因素：一项定性证据综合分析
Campbell Syst Rev. 2022 Apr 25;18(2):e1237. doi: 10.1002/cl2.1237. eCollection 2022 Jun.
4
Guidance for engagement in health guideline development: A scoping review.参与健康指南制定的指导意见：一项范围综述
Campbell Syst Rev. 2024 Nov 25;20(4):e70006. doi: 10.1002/cl2.70006. eCollection 2024 Dec.
5
Stakeholder involvement: how to do it right: article 9 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.利益相关者的参与：如何正确进行：COPD 指南制定中整合和协调工作的第 9 条。美国胸科学会/欧洲呼吸学会官方研讨会报告。
Proc Am Thorac Soc. 2012 Dec;9(5):269-73. doi: 10.1513/pats.201208-062ST.
6
Key issues for stakeholder engagement in the development of health and healthcare guidelines.利益相关者参与健康与医疗保健指南制定过程中的关键问题。
Res Involv Engagem. 2023 Apr 28;9(1):27. doi: 10.1186/s40900-023-00433-6.
7
Protocol for a scoping review on the methods for engaging long-term care residents with dementia in research and guideline development.关于在研究和指南制定中让患有痴呆症的长期护理居民参与的方法的范围综述协议。
BMJ Open. 2021 Aug 25;11(8):e051602. doi: 10.1136/bmjopen-2021-051602.
8
A Protocol of a Guideline to Establish the Evidence Ecosystem of Acupuncture.建立针灸证据生态系统指南的方案
Front Med (Lausanne). 2022 Feb 15;8:711197. doi: 10.3389/fmed.2021.711197. eCollection 2021.
9
PROTOCOL: Guidance for stakeholder engagement in guideline development: A systematic review.方案：利益相关者参与指南制定的指导意见：一项系统评价
Campbell Syst Rev. 2022 May 11;18(2):e1242. doi: 10.1002/cl2.1242. eCollection 2022 Jun.
10
Protocol: Assessing the impact of interest-holder engagement on guideline development: A systematic review.方案：评估利益相关者参与对指南制定的影响：一项系统评价。
Campbell Syst Rev. 2024 Oct 15;20(4):e1444. doi: 10.1002/cl2.1444. eCollection 2024 Dec.
引用本文的文献
1
A bespoke rapid evidence review process engaging stakeholders for supporting evolving and time-sensitive policy and clinical decision-making: reflection and lessons learned from the Wales COVID-19 Evidence Centre 2021-2023.一个定制的快速证据审查过程，让利益相关者参与其中，以支持不断演变且具有时间敏感性的政策和临床决策：来自威尔士新冠病毒证据中心2021 - 2023年的反思与经验教训
Health Res Policy Syst. 2025 Mar 20;23(1):36. doi: 10.1186/s12961-025-01297-w.
2
Guidance for engagement in health guideline development: A scoping review.参与健康指南制定的指导意见：一项范围综述
Campbell Syst Rev. 2024 Nov 25;20(4):e70006. doi: 10.1002/cl2.70006. eCollection 2024 Dec.
3
Protocol: Assessing the impact of interest-holder engagement on guideline development: A systematic review.方案：评估利益相关者参与对指南制定的影响：一项系统评价。
Campbell Syst Rev. 2024 Oct 15;20(4):e1444. doi: 10.1002/cl2.1444. eCollection 2024 Dec.
4
Leveling the Research Playing Field: Decolonizing Global Health Research Through Web-Based Platforms.拉平研究领域：通过基于网络的平台实现全球健康研究去殖民化。
J Med Internet Res. 2023 Oct 31;25:e46897. doi: 10.2196/46897.
5
PROTOCOL: Barriers and facilitators to stakeholder engagement in health guideline development: A qualitative evidence synthesis.方案：利益相关者参与健康指南制定的障碍与促进因素：一项定性证据综合分析
Campbell Syst Rev. 2022 Apr 25;18(2):e1237. doi: 10.1002/cl2.1237. eCollection 2022 Jun.
本文引用的文献
1
Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation.卫生与医疗保健指南制定和实施中利益相关者参与指南制定的指导方针制定议定书。
Syst Rev. 2020 Feb 1;9(1):21. doi: 10.1186/s13643-020-1272-5.
2
Financial relationships between patient and consumer representatives and the health industry: A systematic review.患者和消费者代表与卫生行业之间的财务关系：系统评价。
Health Expect. 2020 Apr;23(2):483-495. doi: 10.1111/hex.13013. Epub 2019 Dec 19.
3
Engaging Patients and Other Non-Researchers in Health Research: Defining Research Engagement.让患者及其他非研究人员参与健康研究：界定研究参与度。
J Gen Intern Med. 2020 Jan;35(1):307-314. doi: 10.1007/s11606-019-05436-2. Epub 2019 Nov 11.
4
Development of the ACTIVE framework to describe stakeholder involvement in systematic reviews.用于描述利益相关者参与系统评价的ACTIVE框架的开发。
J Health Serv Res Policy. 2019 Oct;24(4):245-255. doi: 10.1177/1355819619841647. Epub 2019 Apr 18.
5
Stakeholder involvement in systematic reviews: a scoping review.利益相关者参与系统评价：范围综述。
Syst Rev. 2018 Nov 24;7(1):208. doi: 10.1186/s13643-018-0852-0.
6
Institutional Conflicts of Interest and Public Trust.机构利益冲突与公众信任。
JAMA. 2018 Dec 11;320(22):2305-2306. doi: 10.1001/jama.2018.18482.
7
Prevalence of Financial Conflicts of Interest Among Authors of Clinical Guidelines Related to High-Revenue Medications.高收益药物相关临床指南作者的财务利益冲突发生率。
JAMA Intern Med. 2018 Dec 1;178(12):1712-1715. doi: 10.1001/jamainternmed.2018.5106.
8
How to incorporate patient and public perspectives into the design and conduct of research.如何将患者和公众的观点纳入研究的设计与实施过程中。
F1000Res. 2018 Jun 18;7:752. doi: 10.12688/f1000research.15162.1. eCollection 2018.
9
Management of financial conflicts of interests in clinical practice guidelines in Germany: results from the public database GuidelineWatch.德国临床实践指南中财务利益冲突的管理：来自公共数据库GuidelineWatch的结果。
BMC Med Ethics. 2018 Jun 28;19(1):65. doi: 10.1186/s12910-018-0309-y.
10
Conflicts of Interest of Public Speakers at Meetings of the Anesthetic and Analgesic Drug Products Advisory Committee.会议麻醉和镇痛药物产品咨询委员会演讲者的利益冲突。
JAMA Intern Med. 2018 Jul 1;178(7):996-997. doi: 10.1001/jamainternmed.2018.1325.
Zotero 插件